Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Stanford Health Care

Challenges and Priorities for Children With Congenital Valvar Heart Disease: The Heart Valve Collaboratory.

Challenges and Priorities for Children With Congenital Valvar Heart Disease: The Heart Valve Collaboratory. JACC. Advances Bauser-Heaton, H., Barry, O. M., Hofferberth, S. C., Tretter, J. T., Ma, M., Goldstone, A., Armstrong, A., Jones, T. K., Yoganathan, A., Del Nido, P. 2024; 3 (10): 101191

Abstract

The Heart Valve Collaboratory is a multidisciplinary, patient-centered community of stakeholders addressing complex problems and embracing innovation to help patients with heart valve disease achieve their fullest potential for health. The Scientific Council is composed of cardiologists, surgeons, ex-officio representatives of the Food and Drug Administration and Centers for Medicare and Medicaid Services, National Heart Lung Blood Institute, and representatives from industry partners. In October 2022, this group convened a workshop that included experts from stakeholder groups to address the unmet and clinical needs of patients with pediatric and congenital heart valve disease. The following document includes the discussion and summary of the current state of valve therapy and the needs being addressed forvalve development.

View details for DOI 10.1016/j.jacadv.2024.101191

View details for PubMedID 39290810